Leveraging continuous glucose monitoring as a catalyst for behaviour change: a scoping review.

Autor: Jospe MR; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA., Richardson KM; School of Nutritional Sciences and Wellness, College of Agriculture, Life and Environmental Sciences, University of Arizona, Tucson, AZ, USA., Saleh AA; Arizona Health Sciences Library, University of Arizona, Tucson, AZ, USA., Bohlen LC; Center for Health Promotion and Health Equity, Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA., Crawshaw J; Centre for Implementation Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Liao Y; Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX, USA., Konnyu K; Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland., Schembre SM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA. ss4731@georgetown.edu.
Jazyk: angličtina
Zdroj: The international journal of behavioral nutrition and physical activity [Int J Behav Nutr Phys Act] 2024 Jul 10; Vol. 21 (1), pp. 74. Date of Electronic Publication: 2024 Jul 10.
DOI: 10.1186/s12966-024-01622-6
Abstrakt: Background: Amidst the escalating prevalence of glucose-related chronic diseases, the advancements, potential uses, and growing accessibility of continuous glucose monitors (CGM) have piqued the interest of healthcare providers, consumers, and health behaviour researchers. Yet, there is a paucity of literature characterising the use of CGM in behavioural intervention research. This scoping review aims to describe targeted populations, health behaviours, health-related outcomes, and CGM protocols in randomised controlled trials (RCTs) that employed CGM to support health behaviour change.
Methods: We searched Ovid MEDLINE, Elsevier Embase, Cochrane Central Register of Controlled Trials, EBSCOhost PsycINFO, and ProQuest Dissertations & Theses Global from inception to January 2024 for RCTs of behavioural interventions conducted in adults that incorporated CGM-based biological feedback. Citation searching was also performed. The review protocol was registered ( https://doi.org/10.17605/OSF.IO/SJREA ).
Findings: Collectively, 5389 citations were obtained from databases and citation searching, 3995 articles were screened, and 31 were deemed eligible and included in the review. Most studies (n = 20/31, 65%) included adults with type 2 diabetes and reported HbA1c as an outcome (n = 29/31, 94%). CGM was most commonly used in interventions to target changes in diet (n = 27/31, 87%) and/or physical activity (n = 16/31, 52%). 42% (n = 13/31) of studies provided prospective CGM-based guidance on diet or activity, while 61% (n = 19/31) included retrospective CGM-based guidance. CGM data was typically unblinded (n = 24/31, 77%) and CGM-based biological feedback was most often provided through the CGM and two-way communication (n = 12/31, 39%). Communication typically occurred in-person (n = 13/31, 42%) once per CGM wear (n = 13/31; 42%).
Conclusions: This scoping review reveals a predominant focus on diabetes in CGM-based interventions, pointing out a research gap in its wider application for behaviour change. Future research should expand the evidence base to support the use of CGM as a behaviour change tool and establish best practices for its implementation.
Trial Registration: doi.org/10.17605/OSF.IO/SJREA.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje